Opioids

A randomised controlled trial (RCT) to assess the acceptability of a switch from buprenorphine-naloxone (Suboxone®) sublingual tablets to buprenorphine-naloxone sublingual film

The majority of buprenorphine-naloxone (Suboxone®) dosing in Australia involves supervised dosing of sublingual tablets in order to enhance medication adherence and to minimise aberrant behaviours such as diversion and/or injecting.

Project Status:

Completed

Pathways to heroin dependence: the role of self-medication

In this review, the self-medication hypothesis is examined in relation to the development and chronicity of heroin dependence.

Project Status:

Completed

Tasmanian Review of Opioid Prescribing

Project Status:

Current

Child protection and mothers in substance abuse treatment

Project Status:

Completed

Development of an opioid aberrant drug behaviour scale for use in multiple healthcare settings

An emerging body of literature from the United States (US) describes ‘aberrant’ (i.e. divergent) medication-related behaviours among pain patients, and the extent to which they are associated with harm, including medical morbidity, dependence and diversion.

Project Status:

Completed